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Summary
Protein quality control degradation systems rid the
cell of aberrant proteins, preventing detrimental ef-
fects on normal cellular function. Although such sys-
tems have been identified in most subcellular com-
partments, none have been found in the nucleus.
Here, we report the discovery of such a system in
Saccharomyces cerevisiae. It is defined by San1p, a
ubiquitin-protein ligase that, in conjunction with the
ubiquitin-conjugating enzymes Cdc34p and Ubc1p,
targets four distinct mutant nuclear proteins for
ubiquitination and destruction by the proteasome.
San1p has exquisite specificity for aberrant proteins
and does not target the wild-type versions of its mu-
tant substrates. San1p is nuclear localized and re-
quires nuclear localization for function. Loss of SAN1
results in a chronic stress response, underscoring its
role of protein quality control in the cell. We propose
that San1p-mediated degradation acts as the last line
of proteolytic defense against the deleterious accu-
mulation of aberrant proteins in the nucleus and that
analogous systems exist in other eukaryotes.
Introduction
Aberrant proteins can be produced in the cell by muta-
tion, transcriptional or translational errors, incorrect
folding, imbalanced subunit synthesis, improper traf-
ficking, or damage caused by environmental conditions
or metabolic byproducts (Goldberg, 2003). Accumula-
tion or persistence of aberrant proteins within the cell
can often have deleterious consequences. For exam-
ple, aberrant proteins may lose regulation, may form
inactive complexes that compete with functional com-
plexes, may assemble into aggregates that eliminate
protein function or cause toxicity, or may introduce
harmful activities if mislocalized. In humans, accumula-
tion of aberrant proteins may underlie the pathology of
diseases such as Alzheimer’s, Huntington’s, Parkin-
son’s, and prion pathologies like Creutzfeld-Jakob’s
(Shastry, 2003).
To minimize harmful effects from aberrant proteins,
the cell possesses a set of protein quality control (PQC)
systems that operate in distinct ways. Some PQC sys-
tems function in repair, such as protein chaperones that
refold or sequester aberrantly folded proteins (Stirling
et al., 2003). Protein chaperones reside in every major
cellular compartment and function either by refolding
misfolded proteins (e.g., Hsp70 and Hsp90), binding to*Correspondence: dgottsch@fhcrc.orgmisfolded proteins and preventing aggregation (e.g.,
Hsp40), or disrupting protein aggregates (e.g., Hsp104).
Not all aberrant proteins can be repaired, however. For
these lost causes, the cell has PQC systems that func-
tion in disposal, such as proteolytic systems that de-
stroy proteins that are mutant, damaged, or misfolded
and recalcitrant to refolding (Goldberg, 2003). PQC de-
gradation systems have been identified in the cyto-
plasm, the secretory pathway, and mitochondria. In the
cytoplasm and endoplasmic reticulum (ER), PQC de-
gradation is primarily brought about by protein-ubiquiti-
nation complexes that mark proteins for proteasomal
degradation (Hampton, 2002; McDonough and Patter-
son, 2003; Trombetta and Parodi, 2003). PQC degrada-
tion in the cytoplasm and ER can also occur via trans-
port to the lysosome/vacuole (Trombetta and Parodi,
2003). In the mitochondria, localized proteases function
in PQC degradation (Arnold and Langer, 2002). Repair
and degradation systems may not be mutually exclu-
sive, as various protein chaperones appear to interface
with PQC degradation systems (McDonough and Pat-
terson, 2003; Trombetta and Parodi, 2003).
How the cell targets and destroys aberrant proteins
depends upon how and when aberrant proteins are
produced. Aberrant proteins may be evident immedi-
ately upon production due to errors in synthesis or fold-
ing. It is estimated that nearly a third of all newly syn-
thesized proteins are defective and destroyed during or
shortly after synthesis (Schubert et al., 2000), indicating
that PQC degradation systems may be intimately linked
with the production process. Properly synthesized pro-
teins can become aberrant even after they are perform-
ing their normal functions. Postproduction damage can
be caused by physical or chemical means including
heat, irradiation, free radicals, and changes in hydration
or osmolarity (Goldberg, 2003). It is not clear if particu-
lar PQC degradation systems are dedicated exclusively
to production-level defects or postproduction damage
or if they target both classes of aberrant proteins.
In contrast to the cytoplasm, ER, and mitochondria,
very little is known about PQC in the nucleus. A number
of chaperones have been implicated in protein refolding
and disaggregation in the nucleus (Parsell et al., 1994;
Rossi and Lindquist, 1989), but no nuclear PQC degra-
dation systems have been identified. Because there is
no functional protein synthesis in the nucleus, the cell
would not have to contend with production defects in
the nucleus unless they eluded cytoplasmic PQC sys-
tems. Nuclear proteins can be damaged by the same
stresses that damage proteins in other cellular com-
partments; thus, the cell must contend with aberrant
proteins that arise within the nucleus. It is not clear if
PQC degradation systems exist in the nucleus and, if
so, whether they would be similar to those in other cel-
lular compartments where protein synthesis occurs.
Yet, similar to the protein synthetic compartments, ac-
cumulation of aberrant proteins in the nucleus can have
deleterious effects. For example, aberrant protein ac-
cumulation in the nucleus likely underlies the pathology
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804of Huntington’s disease (HD) and oculopharyngeal t
rmuscular dystrophy (OPMD) (Brais, 2003; Jana and
Nukina, 2003). With a significant amount of regulated N
pdegradation occurring in the nucleus via ubiquitination
and nuclear-localized proteasomes (Wojcik and DeMar- d
Stino, 2003), the nucleus certainly has the potential
machinery for PQC degradation. In fact, nuclear ag- T
cgregates of mutant polyglutamine- and polyalanine-
expanded proteins in HD and OPMD, respectively, are S
ubiquitinated and associated with proteasome subunits
(Abu-Baker et al., 2003; Calado et al., 2000; Davies et s
aal., 1997; Waelter et al., 2001), providing some evidence
that PQC degradation systems may be operating in t
Sthe nucleus.
Given the potential importance of PQC degradation o
(in the nucleus, we asked if such a system existed in the




tMutant Nuclear Proteins Are Degraded
pin a SAN1-Dependent Manner
oWe searched for nuclear PQC degradation pathways in
(yeast working under the assumption that temperature-
sensitive mutant nuclear proteins might be substrates
wfor such a pathway. This idea was based on the obser-
ovation that some temperature-sensitive proteins in
pother cellular compartments are recognized as aberrant
band destroyed by PQC machinery, despite the fact that
pthe mutant proteins often possess normal or near-nor-
pmal activity (Betting and Seufert, 1996; Bordallo et al.,
e1998). In these cases, the temperature-sensitive pheno-
atype results from reduced steady-state levels of the
Dprotein and can be suppressed by inhibiting the pro-
mtein’s degradation, thus allowing the mutant protein to
Naccumulate to functional levels (Bordallo et al., 1998).
LWe speculated that if a general nuclear-localized
(PQC degradation system exists, then the temperature-
Ssensitive phenotypes of different mutant nuclear pro-
wteins with disparate normal functions would be sup-
apressed by a common extragenic mutation. We focused
Con temperature-sensitive alleles of nuclear protein
wgenes that had been previously identified, particularly
tthose for which suppressor analyses had been re-
Sported. From our search, we found two independently
conducted genetic analyses: one targeting the sir4-9
Callele (Schnell et al., 1989) and the other targeting the
8cdc68-1 allele (Xu et al., 1993). Both analyses identified
tmutations in the gene SAN1 that suppressed the re-
Tspective temperature-sensitive phenotypes. SAN1 made
tan excellent candidate gene for a nuclear PQC degra-
(dation factor given the different nuclear functions of
sSir4p, which is a structural component of silent chromatin
nat the silent mating-type loci and telomeres (Aparicio et
lal., 1991; Rine and Herskowitz, 1987), and Cdc68p,
rwhich facilitates DNA replication, transcriptional initia-
stion, and elongation (Belotserkovskaya et al., 2003;
dBrewster et al., 2001; Formosa et al., 2001). In fact, the
mutant Cdc68-1 protein was previously shown to be
unstable compared to wild-type Cdc68p (Xu et al., S
A1995), and SAN1 was required for the mutant protein’s
degradation (Evans et al., 1998). a
rTo assess San1p’s role in the QC degradation of mu-ant nuclear proteins, we first confirmed the SAN1
equirement for Cdc68-1p degradation (Figure 1A).
ext, we examined the stability of the mutant Sir4-9
rotein and found that it too was degraded in a SAN1-
ependent manner, whereas the wild-type version of
ir4p was stable in the presence of SAN1 (Figure 1B).
hus, mutations in both the Sir4 and Cdc68 proteins
aused them to be rapidly degraded in the presence of
AN1, while their wild-type counterparts were stable.
To facilitate additional genetic and biochemical as-
ays, single Myc-tagged versions of wild-type Sir4p
nd the mutant Sir4-9p were created. While we found
hat N- or C-terminal addition of epitope sequences to
ir4p abrogated its silencing function and, in the case
f N-terminal tags, resulted in aberrant degradation
data not shown), we found that conversion of the in-
ernal native sequence of Sir4p, 372EQKMKEDADL, to
he highly similar c-Myc epitope sequence, EQKLIS
EDL, had no effect on SIR4 silencing function (data
ot shown). Furthermore, overexpression of each in-
ernal Myc-tagged protein from the constitutive TDH3
romoter did not alter the stability of wild-type Sir4p
r the SAN1-dependent degradation of mutant Sir4-9p
Figure 1C).
We next determined if San1p’s degradative function
as limited to the mutant Sir4-9 and Cdc68-1 proteins
r if San1p acted more generally in aberrant nuclear
rotein degradation. To do so, we examined the sta-
ility of two other temperature-sensitive mutant nuclear
roteins, Cdc13-1p and Sir3-8p. Detection of Cdc13
roteins was facilitated by the addition of a 9× Myc
pitope sequence to the C terminus, which does not
lter wild-type Cdc13p function (Qi and Zakian, 2000).
etection of Sir3 proteins was facilitated by replace-
ent of the wild-type Sir3p sequence, 426ETDNEMNG
GK, with the VSV epitope sequence, 426YTDIEMNR
GK, which had no effect on SIR3 silencing function
data not shown). Similar to the mutant Cdc68-1 and
ir4-9 proteins, the mutant Cdc13-1 and Sir3-8 proteins
ere rapidly degraded, and each was stabilized in the
bsence of SAN1 (Figures 1D and 1E, respectively).
dc13-1p stabilization in san1 cells was complete,
hereas Sir3-8p stabilization was partial. Both wild-
ype Cdc13p and Sir3p were stable in the presence of
AN1 (Figures 1D and 1E, respectively).
Although the absence of SAN1 stabilized both
dc13-1p and Sir3-8p, neither the cdc13-1 nor the sir3-
temperature-sensitive phenotype was suppressed by
he san1D allele (data not shown; Schnell et al., 1989).
his lack of phenotypic suppression contrasted with
he san1D effect on the sir4-9 and cdc68-1 phenotypes
Schnell et al., 1989; Xu et al., 1993), indicating that the
tabilized Cdc13-1 and Sir3-8 proteins are likely to be
onfunctional at the restrictive temperatures. Neverthe-
ess, the fact that all four mutant proteins were aber-
antly degraded in a SAN1-dependent manner is con-
istent with San1p functioning in nuclear PQC
egradation.
an1p Is a RING-Domain Ubiquitin-Protein Ligase
nalysis of its sequence revealed that San1p contained
variant version of the canonical RING domain (from
esidues 165–279; Figure 2A), which is common among
Nuclear Protein Quality Control Degradation
805Figure 1. Degradation of Mutant Nuclear Proteins Requires SAN1
Cycloheximide-chase assays of cells expressing the indicated wild-type or mutant protein were performed to assess stability in the presence
or absence of SAN1. Time after addition of cycloheximide is indicated above each lane. Images are of the same blot, first probed with either
anti-Cdc68p, anti-Sir4p, anti-Myc, or anti-VSV antibodies to detect the appropriate protein and subsequently probed with anti-Sir2p antibod-
ies to assess Sir2p levels as a loading control.
(A) Cdc68-1p degradation, (B) Sir4-9p degradation, (C) 1Myc-Sir4-9p degradation, with expression from the TDH3 promoter, (D) 9Myc-Cdc13-
1p degradation, and (E) 1VSV-Sir3-8p degradation, with expression from the TDH3 promoter.for ubiquitin-protein ligase activity, we used a standard GST-San1p fusion (Figure 2C). Thus, San1p possessed
Figure 2. San1p Is a Ubiquitin-Protein Ligase
(A) The RING domain of San1p is compared to
the RING domain of five yeast and two mam-
malian ubiquitin-protein ligases. Consensus
RING domain is in gray on the bottom. Zinc
binding cysteine and histidine residues are
in large typeface. The “B” represents a bulky,
hydrophobic residue common among ubiqu-
itin-protein ligases. The arrow points to the
noncanonical glycine in San1p’s RING
domain.
(B) Purified GST-San1p was added to a reac-
tion containing ubiquitin-activating enzyme
(UBA), ubiquitin-conjugating enzyme (UBC),
ubiquitin (Ub), and ATP. Dashes above gel
lanes indicate which reagent was excluded
from final reaction mixture. Blot was probed
with a monoclonal anti-ubiquitin antibody.
Numbers on left indicate positions of protein
molecular weight markers.
(C) San1p ubiquitin-protein ligase activity re-
quires the RING domain. Purified GST-San1p
containing the indicated mutations was used
in an in vitro ubiquitin-ligase assay de-
scribed in (B).
(D) San1p is required for Sir4-9p ubiquitination in vivo. Sir4 protein was immunoprecipitated from lysates of cells expressing either 1Myc-
Sir4-9p, 1Myc-Sir4p, or no Sir4p, and the indicated SAN1 allele. Blots of the immunoprecipitates were probed with anti-HA antibodies to
detect ubiquitin (top panel) or anti-Myc antibodies to assess Sir4p levels (bottom panel).a subset of ubiquitin-protein ligases (Jackson et al.,
2000). In San1p’s RING domain, the fifth canonical zinc
binding His/Cys residue is replaced by Gly (Figure 2A).
Because mutation of any of the conserved zinc binding
Cys or His residues results in loss of activity in other
ubiquitin-protein ligases tested (Bays et al., 2001;
Joazeiro et al., 1999; Lorick et al., 1999), the presence
of a Gly residue in this position might be expected to
disrupt RING domain structure and impair or prevent
potential ubiquitin-protein ligase activity. To test San1pin vitro autoubiquitination assay (Joazeiro et al., 1999;
Lorick et al., 1999). The addition of a purified GST fu-
sion of San1p to purified ubiquitin-activating enzyme,
ubiquitin-conjugating enzyme, ubiquitin, and ATP re-
sulted in autoubiquitination of GST-San1p (Figure 2B).
This effect was not observed with GST alone or when
any critical component of the reaction was excluded
(Figure 2B). The activity was also RING domain depen-
dent, as replacement of either Cys257 or Cys279 with
Ser abolished the ubiquitin-protein ligase activity of the
Cell
806in vitro RING-dependent ubiquitin-protein ligase activ- f
City, which is in agreement with recent findings (Das-
gupta et al., 2004). l
Next, we assessed San1p activity in vivo by determin-
ing if one of its cellular substrates, Sir4-9p, was ubiquiti- t
Cnated in a San1p-dependent manner. Immunoprecipitates
of Sir4-9p contained high molecular weight ubiquitin o
wconjugates that increased dramatically after incubation
at the nonpermissive temperature (Figure 2D), consis- t
rtent with the temperature-sensitive degradation of Sir4-
9p. Importantly, the ubiquitination of Sir4-9p required (
athe presence of SAN1. Furthermore, SAN1-dependent
ubiquitination was specific for only the mutant Sir4-9p, N
ias the stable wild-type Sir4p showed no ubiquitination.
Together, our in vivo and in vitro observations indicate w
Sthat San1p is a ubiquitin-protein ligase that acts in the




Nuclear Localization of San1p Is Required g
for Its Function o
It was evident that San1p was involved in the QC de- d
gradation of mutant nuclear proteins, but it was not a
clear if San1p carried out its function in the nucleus per o
se. Indeed, San1p resides in the nucleus, as evidenced
by colocalization of GFP-tagged San1p with DAPI-
stained nuclear DNA (Figure 3B). By analyzing San1p’s U
Msequence with PROSITE (http://au.expasy.org/prosite/),
we found that San1p has a putative bipartite nuclear- I
llocalization sequence (NLS) from residues 182–199
(Figure 3A). In fact, the NLS was bona fide, as mutagen- a
zesis of the San1p NLS (Lys182Cys, Arg183Ser, Lys-
184Ala, Arg185Thr, Lys197Ser, Lys198Gln, Arg199Ser) e
aresulted in predominantly cytoplasmic localization (Fig-
ure 3C). Although the NLS resides within a loop of the a
zRING domain, RING domain structure was not criticalFigure 3. San1p Is Nuclear Localized
(A) The San1p RING domain. Zinc binding cysteine and histidine residues are in large black typeface. Residues comprising the bipartite
nuclear localization sequence are in large gray typeface, with the entire sequence underlined.
(B–F) Cells expressing the indicated San1p-3HSV-GFP fusion were fixed with 4% paraformaldehyde, stained with DAPI, and examined by
fluorescence microscopy as previously described (Biggins et al., 1999). Single cell images were taken showing different stages of the cell
cycle. Left panels show GFP fluorescence, middle panels show DAPI-stained DNA, and right panels show bright field images. Cells expressing
(B) SAN1-3HSV-GFP, (C) SAN1(-NLS)-3HSV-GFP, (D) SAN1(-NLS)-3HSV-SV40NLS-GFP, (E) SAN1(C257S)-3HSV-GFP, or (F) SAN1(C279S)-
3HSV-GFP are shown.or nuclear localization, as substitution of Cys257 or
ys279 with Ser had no effect on San1p-GFP nuclear
ocalization (Figures 3E and 3F).
Importantly, mislocalization of San1p by the NLS mu-
ations abrogated the degradation of Sir4-9p and
dc68-1p and suppressed the temperature sensitivity
f cdc68-1 cells in a manner similar to that observed
hen SAN1 was deleted or the RING domain was mu-
ated (Figure 4). However, the NLS-deficient San1p still
etained normal ubiquitin-protein ligase activity in vitro
Figure 2C), indicating that mutation of the NLS did not
dversely affect RING-domain activity. Curiously, the
LS mutations resulted in a slower mobility of San1p
n SDS-PAGE gels (Figures 4A and 4B). It is not clear
hy this change occurred; perhaps the NLS-deficient
an1 protein was subject to additional or new modifica-
ions that also interfered with San1p function. To rule
ut this possibility, we added the SV40 NLS onto the
terminus of the NLS-deficient San1p. This addition
estored nuclear localization (Figure 3D) and in vivo de-
radation function (Figure 4), indicating that disruption
f San1p nuclear localization by mutations to the en-
ogenous NLS simply prevented San1p from gaining
ccess to its nuclear substrates and did not alter an-
ther function of San1p.
bc1p and Ubc3p/Cdc34p Function in San1p-
ediated Degradation
n addition to a ubiquitin-protein ligase (E3), the cova-
ent attachment of ubiquitin to substrates requires the
ction of two other enzymes: a ubiquitin-activating en-
yme (UBA or E1), which forms a high-energy, thiol-
ster bond with ubiquitin in a reaction that requires ATP,
nd a ubiquitin-conjugating enzyme (UBC or E2), which
ccepts the charged ubiquitin from the activating en-
yme by forming an identical, high-energy, thiol-ester
Nuclear Protein Quality Control Degradation
807Figure 4. Nuclear Localization of San1p Is Required for Function
(A and B) Cycloheximide-chase assays of cells expressing the indicated San1p substrates were performed to assess stability in the presence
of various san1 alleles. Images are of the same blot, probed sequentially with anti-Myc or anti-Cdc68p antibodies, anti-HSV antibodies, and
anti-Sir2p antibodies. The degradation of (A) 1Myc-Sir4-9p and (B) Cdc68-1p was analyzed.
(C) Strains containing the indicated SAN1 and CDC68 alleles were streaked onto YC Trp plates and incubated at the indicated temperatures
for 3 days. Gray triangles in the plate map indicate strains in which the indicated SAN1-3HSV allele covered the san1D allele.bond with ubiquitin (Jackson et al., 2000). S. cerevisiae
has a single essential UBA, Uba1p, and eleven UBCs,
ten of which are not essential for viability (Jackson et
al., 2000).
To identify the UBC(s) participating in SAN1-medi-
ated degradation, Sir4-9p degradation was examined
in the absence of each nonessential UBC gene. ubc1D
was the only single null allele that had a detectable ef-
fect on Sir4-9p degradation (Figure 5A). However, loss
of UBC1 resulted in partial stabilization of Sir4-9p, un-
like the san1D allele, indicating that Ubc1p likely acts
in concert with another UBC and San1p to ubiquitinate
target proteins. Accumulation of Sir4-9p proteolytic
fragments in ubc1D cells (Figure 5A, arrows) might indi-
cate that Ubc1p activity is important in a processive
aspect of SAN1-mediated degradation.
The remaining untested UBC was CDC34/UBC3,
which is a member of the SCF complex and is essential
for yeast cells to progress through the cell cycle (Des-
haies, 1999). To assess a possible role of CDC34 in
San1p-mediated degradation, we analyzed Sir4-9p de-
gradation in a strain carrying the cdc34-2 allele (Liu et
al., 1995). When compared to a wild-type CDC34 strain,
Sir4-9p was stable in the cdc34-2 strain (Figure 5B).
Degradation was restored when the cdc34-2 allele was
complemented by introduction of the wild-type CDC34
gene (Figure 5B), indicating that the cdc34-2 allele itself
was responsible for Sir4-9p stability.We further tested the involvement of UBC1 and
CDC34 in SAN1-mediated degradation by examining
the effect of overexpressing catalytically inactive ver-
sions of each UBC on Sir4-9p degradation. Mutation
of the active-site Cys residue in UBCs destroys their
function, and overexpression of the mutant can domi-
nantly interfere with the function of the wild-type cog-
nate (Banerjee et al., 1995; Madura et al., 1993). We
created catalytically inactive mutants by substituting a
Ser at Cys88 for Ubc1p and at Cys95 for Cdc34p. Over-
expression of either mutant UBC from the galactose-
inducible GAL1,10 promoter significantly stabilized
Sir4-9p (Figure 5C).
Given the nuclear-restricted activity of SAN1 and
nuclear localization of Sir4p (Palladino et al., 1993), it
was possible that overexpression of any nuclear-local-
ized catalytically inactive UBC might affect Sir4-9p
degradation. To address this, we made a catalytically
inactive variant of Rad6/Ubc2p, which is located in the
nucleus (Ulrich and Jentsch, 2000). In contrast to
CDC34C95S or UBC1C88S, RAD6C88S overexpression had
little effect on Sir4-9p degradation (Figure 5C).
Ubc1p also functions with Ubc7p in degradation of
proteins at the ER (Bays et al., 2001; Friedlander et al.,
2000). However, loss of UBC7 or overexpression of the
UBC7C89S allele did not stabilize Sir4-9p (Figures 5A
and 5C), indicating that Ubc1p function in Sir4-9p deg-
radation is distinct from its ER function. The lack of
Cell
808Figure 5. Ubc1p and Cdc34p Are Required for Optimal Degradation of San1p Substrates
(A) Cycloheximide-chase assays of cells expressing 1Myc-Sir4-9p were performed to assess stability in the absence of the individual UBC
genes. Images are of the same blot, probed sequentially with anti-Sir4p antibodies and anti-Sir2p antibodies.
(B) Cycloheximide-chase assays of cells expressing 1Myc-Sir4-9p were performed to assess stability in the presence of the cdc34-2 allele.
Images are of the same blot, sequentially probed with anti-Myc antibodies and anti-Sir2p antibodies.
(C) Cycloheximide-chase assays of cells expressing 1Myc-Sir4-9p were performed to assess stability in the presence of the individual catalyti-
cally inactive CDC34C95S, UBC1C88S, UBC7C89S, and RAD6C88S alleles. Images are of the same blot, which was probed as in (B).effect seen with the UBC7C89S and RAD6C88S alleles in- H
tdicates that Sir4-9p stabilization due to overexpression
of the CDC34C95S or UBC1C88S alleles is not a general t
mfeature of overexpressing dominant-negative versions
of UBCs. Similar stabilizing effects on Cdc68-1p degra- a
gdation were observed after overexpression of the
UBC1C88S or CDC34C95S alleles but not the UBC7C89S m
Wor RAD6C88S alleles (data not shown).
s
cThe Proteasome Is the Primary Protease Involved
in San1p-Mediated Degradation t
lBecause SAN1-mediated degradation is ubiquitin de-
pendent, the proteasome is the likely protease involved. t
mIn fact, the previously described cdc68-1 suppressor
analysis identified mutations in the proteasomal 19S 1
lregulatory particle subunit RPT6/SUG1/CIM3 that sup-
pressed cdc68-1 temperature sensitivity (Xu et al., f
S1993; Xu et al., 1995). To test this idea more thoroughly,
we examined the degradation of the Sir4-9 protein in a F
tstrain containing the cim3-1 allele and found that Sir4-
9p was stable (Figure 6A). Sir4-9p was also very stable 2
pin the presence of cim5-1, a mutant allele of another
proteasomal 19S subunit (Figure 6A). Finally, to test i
Twhether the proteasome’s 20S catalytic activity was re-
quired for SAN1-mediated degradation, we added the a
2proteasome inhibitor MG-132 to cells and assayed for
protein stability. Addition of MG-132 stabilized Sir4-9p, d
mCdc13-1p, and Cdc68-1p (Figure 6B). Thus, SAN1-
dependent QC degradation requires a functional 26S i
rproteasome.
S
tSan1p Does Not Regulate Wild-Type Versions
of Its Mutant Substrates n
Our observations support a model in which San1p is
part of a nuclear-localized PQC degradation machinery. wowever, San1p could also be a regulator of the wild-
ype proteins whose mutant versions were its degrada-
ion substrates. To see if this were the case, we deter-
ined if loss of SAN1 affected any functions normally
ssociated with the wild-type proteins. Cdc13p is a sin-
le-stranded DNA binding protein that regulates telo-
ere length (Smogorzewska and de Lange, 2004).
hen we examined telomere length in san1D cells, we
aw no significant difference in global telomere length
ompared to wild-type SAN1 cells (see Figure S1A in
he Supplemental Data available with this article on-
ine). Sir4p and Sir3p function together in silent chroma-
in formation at the silent mating-type loci and telo-
eres (Aparicio et al., 1991; Rine and Herskowitz,
987). When we assayed effects on silencing using te-
omeric reporter genes (Gottschling et al., 1990), we
ound telomeric silencing was unaffected by loss of
AN1 (Figure S1B). Cdc68p functions as part of the
ACT complex in transcriptional initiation and elonga-
ion (Belotserkovskaya et al., 2003; Brewster et al.,
001; Formosa et al., 2001). When comparing gene ex-
ression profiles from wild-type or san1D cells grown
n complete synthetic media (YC) or rich media (YEPD;
able 1), we found no difference in expression for genes
ffected by mutations in CDC68/SPT16 (Kaplan et al.,
003; Rowley et al., 1991). We also found no significant
ifference in expression for genes regulated by SIR4-
ediated silent chromatin at telomeres, the silent mat-
ng loci, or for genes regulated by the mating loci (Wy-
ick et al., 1999). Altogether, we found no evidence that
AN1 normally regulates any of the processes in which
he wild-type Cdc13, Sir4, Sir3, and Cdc68 proteins
ormally function.
In contrast to our results, it was recently claimed that
ild-type Sir4p is degraded in a SAN1-dependent man-
Nuclear Protein Quality Control Degradation
809Figure 6. The Proteasome Is Required for Degradation of Mutant
Nuclear Proteins
(A) Cycloheximide-chase assays of cells expressing 1Myc-Sir4-9p
were performed to assess stability in the presence of either the
cim3-1 or cim5-1 alleles. Images are of the same blot, probed se-
quentially with anti-Myc antibodies and anti-Sir2p antibodies.
(B) Cycloheximide-chase assays of cells expressing either wild-
type or mutant protein were performed to assess stability in the
presence or absence of the proteasome inhibitor MG-132. Assays
were performed in pdr5 cells to increase sensitivity of cells to
MG-132 (Chernova et al., 2003). Images are of the same blot, se-
quentially probed with anti-Myc or anti-Cdc68p antibodies and
anti-Sir2p antibodies.ner (Dasgupta et al., 2004). To resolve this difference,
we examined the degradation of wild-type Sir4p in five
different strain backgrounds, including the ones re-
ported in the recent study. We found that wild-type
Sir4p was stable in every strain background tested. In
our hands, mutant Sir4-9p was the only version of Sir4p
that was degraded (Figures 1 and S1C). Although we
cannot explain these differences, we are confident from
our reproducible observations that San1p acts specifi-cally upon mutant versions of Sir4p, Sir3p, Cdc68p, and
Cdc13p and not as a regulator of the wild-type proteins.
A Cellular Stress Response Is Induced
in the Absence of SAN1
Given San1p’s role in degrading aberrant nuclear pro-
teins, we speculated that its activity would be impor-
tant for cellular viability under growth conditions that
create aberrant proteins. Consequently, san1D and
wild-type cells were compared for their ability to grow
at elevated temperatures or in the presence of CdCl2,
in the presence of canavanine, or after exposure to UV,
MMS, EMS, or hydrogen peroxide. In no instance did
we observe a growth difference between SAN1 and
san1D cells (data not shown). In fact, san1 mutant al-
leles have never been identified in any screen looking
for mutations that cause sensitivity to cell stress. A
possible explanation for the lack of a cell-stress pheno-
type is the compensatory upregulation or activation of
other pathways in the absence of SAN1.
To explore this possibility further, we carefully com-
pared the transcript-microarray profiles of wild-type and
san1D cells. When we placed the genes affected dif-
ferentially in san1D cells in order of increased expression,
the top thirty upregulated genes for cells grown in YC
media were highly represented by those that are in-
duced under cellular stress (Causton et al., 2001; Jelin-
sky et al., 2000). Using the Saccharomyces Genome
Database Gene Ontology (GO) Term Finder tool (http://
db.yeastgenome.org/cgi-bin/GO/goTermFinder), 12 of
the 30 genes belonged to the class of proteins involved
in cellular stress (p = 1.2 × 10−8), including seven pro-
tein chaperones: HSP26, HSP12, HSP42, HSP104,
HSP82, HSC82, and SSA4 (Table 1). Furthermore, tran-
script-microarray profiles from the literature revealed
that 29 of the 30 genes are induced 2-fold or greater
under defined cellular stress conditions (Causton et al.,
2001; Jelinsky et al., 2000) and 18 contain a stress re-
sponse element (STRE) in their promoters (Burchett et
al., 2002; Cameroni et al., 2004; DeRisi et al., 1997;
Grant et al., 2000; Lagorce et al., 2003; Moskvina et al.,
1998) or are regulated by MSN2/MSN4 (Causton et al.,
2001). Although the induction of these genes in our
transcript-microarray analysis was modest, ranging
from 1.3- to 2.1-fold increases, independent verification
by quantitative Northern analyses indicated that some
had increased expression by as much as 6-fold (data
not shown).
In contrast, when cells were grown in YEPD media,
there was no similar transcriptional signature for san1D
cells. Fewer genes were upregulated in san1D cells un-
der these conditions, and only three of the top thirty
genes upregulated during growth in synthetic medium
were also upregulated during growth in YEPD (Table 1).
The numerous differences between these growth media
make it difficult to assess the source of the cell stress
resulting from growth in synthetic media. Nevertheless,
our data indicate that san1D cells grown in synthetic
media are under a cellular stress that induces the ex-
pression of numerous protein chaperones that operate
in the nucleus.
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YC Media
ORF Gene Fold Change p Value STRE Stress Induced
YFL014W HSP12 2.1 3.1 × 10−8 Yes1,3,8 Yes3,6
YBR072W HSP26 1.9 5.0 × 10−8 Yes1,3,8 Yes3,6
YNL111C CYB5 1.7 5.8 × 10−7 Yes3,6
YGR234W YHB1 1.6 5.7 × 10−8 Yes6
YJR048W CYC1 1.6 5.1 × 10−8 Yes6
YHR087W 1.5 1.6 × 10−4 Yes1,3 Yes3,6
YML128C MSC1 1.5 5.3 × 10−6 Yes1,3 Yes3,6
YER103W SSA4 1.4 1.1 × 10−6 Yes1,3,8 Yes3,6
YER044C ERG28 1.4 4.6 × 10−6 Yes6
YGR248W SOL4 1.4 1.9 × 10−3 Yes3,4 Yes3, 6
YGR008C STF2 1.4 1.0 × 10−5 Yes1,3 Yes3,6
YLL026W HSP104 1.4 4.4 × 10−4 Yes8 Yes3,6
YDL130W-A STF1 1.4 7.1 × 10−5
YDR070C 1.4 1.0 × 10−4 Yes1,3 Yes3,6
YIL111W COX5B 1.4 2.7 × 10−5 Yes3,8 Yes3,6
YMR251W-A HOR7 1.4 2.9 × 10−4 Yes6
YAR015W ADE1 1.3 3.7 × 10−6 Yes6
YPR160W GPH1 1.3 2.6 × 10−3 Yes1,3,8 Yes3,6
YMR105C PGM2 1.3 2.5 × 10−3 Yes1,3,8 Yes3,6
YKR080W MTD1 1.3 4.4 × 10−5 Yes6
YMR186W HSC82 1.3 2.5 × 10−5 Yes6
YNL015W PBI2 1.3 1.2 × 10−5 Yes3,7 Yes3,6
YMR196W 1.3 1.0 × 10−5 MSN2/MSN43 Yes3
YLR205C HMX1 1.3 4.4 × 10−5 Yes3,6
YLR217W 1.3 3.6 × 10−5 Yes3
YPL240C HSP82 1.3 7.3 × 10−5 Yes6
YDR171W HSP42 1.3 1.7 × 10−3 Yes3,8 Yes3,6
YMR250W GAD1 1.3 1.5 × 10−3 Yes2,3 Yes3,6
YCL035C GRX1 1.3 1.4 × 10−5 Yes3,5 Yes3,6
YFR053C HXK1 1.3 2.4 × 10−3 Yes1,3,8 Yes3,6
YEPD Media
ORF Gene Fold Change p Value STRE Stress Induced
YOL152W FRE7 2.0 3.3 × 10−10
YPR123C 1.6 4.4 × 10−9
YPR124W CTR1 1.5 3.3 × 10−9 Yes6
YGR164W 1.5 2.1 × 10−8
YNL111C CYB5 1.4 1.8 × 10−8 Yes3,6
YLR214W FRE1 1.4 2.6 × 10−8
YJR048W CYC1 1.4 1.8 × 10−5 Yes6
YER044C ERG28 1.4 7.3 × 10−8 Yes6
YML075C HMG1 1.3 4.8 × 10−7
YGR234W YHB1 1.3 5.5 × 10−7 Yes6
YPR200C ARR2 1.3 1.8 × 10−5
YLR158C ASP3-3 1.3 1.6 × 10−7 Yes6
YOL106W 1.3 9.1 × 10−5
Genes whose expression is increased by greater than 1.3-fold in san1 cells compared to wild-type SAN1 cells are listed above. For complete
data set, including genes that are downregulated, see Table S3. Genes that possess a STRE in their promoter are listed. Genes that are
regulated by various stress conditions are annotated with the appropriate references below.
1 Burchett et al., 2002
2 Cameroni et al., 2004
3 Causton et al., 2001
4 DeRisi et al., 1997
5 Grant et al., 2000
6 Jelinsky et al., 2000
7 Lagorce et al., 2003
8 Moskvina et al., 1998Discussion t
n
aSAN1 Defines a Nuclear PQC Degradation System
within the Nucleus w
tIn this study, we provide evidence for a PQC system
that resides within the nucleus and degrades aberrant P
sproteins. The defining member of this degradation sys-em is San1p, a ubiquitin-protein ligase that requires
uclear localization for its proper function. San1p medi-
tes the ubiquitination of aberrant nuclear proteins,
hich ultimately leads to their degradation by the pro-
easome. The critical evidence that San1p is part of a
QC degradation system comes from its specific de-
truction of mutant nuclear proteins, while it leaves the
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811wild-type counterparts of these proteins unscathed. Yet
San1p is not a global degradation factor; loss of SAN1
does not stabilize PQC substrates of the endoplasmic
reticulum (Dasgupta et al., 2004).
Because San1p is a ubiquitin-protein ligase, it must
act in concert with ubiquitin-conjugating enzymes. Of
the eleven UBCs in S. cerevisiae, only mutant alleles of
CDC34 and UBC1 stabilized San1p substrates. For-
mally, it is possible that other UBCs are involved in
San1p-mediated degradation, given that some UBCs
appear to be redundant in other degradation pathways
(Betting and Seufert, 1996; Chen et al., 1993; Seufert
and Jentsch, 1990). Nevertheless, both Ubc1p and
Cdc34p are found in the nucleus (Blondel et al., 2000;
Huh et al., 2003), which is consistent with their role in
the degradation of San1p substrates. Previously, the
only function assigned to Cdc34p was as part of the
SCF complex, where it mediates the regulated ubiquiti-
nation of numerous substrates, including those re-
quired for cell-cycle progression (Deshaies, 1999).
Thus, Cdc34p involvement in nuclear PQC degradation
defines a new role for the UBC. Ubc1p has already been
shown to function in PQC degradation at the ER as part
of the HRD complex (Bays et al., 2001; Friedlander et
al., 2000), so involvement in nuclear PQC degradation
is an extension of Ubc1p function.
The involvement of Cdc34p and Ubc1p in the degra-
dation of San1p substrates and the nature of San1p
itself opens up intriguing parallels with PQC degrada-
tion in the ER, mediated by the RING-domain ubiquitin-
protein ligase Hrd1p (Bays et al., 2001; Deak and Wolf,
2001). The closest homolog to San1p in the S. cerevis-
iae genome is Hrd1p, with 24% identity and 40% sim-
ilarity shared between them in a 174 residue stretch
comprising the RING domain and an adjacent C-ter-
minal region (https://proteome.incyte.com/proteome/
YPD/SAN1.html). Ubc1p is required for both the normal
degradation of Hrd1p-dependent substrates (Bays et
al., 2001; Friedlander et al., 2000) and San1p-depen-
dent substrates (Figure 5). Cdc34p shares the greatest
homology with Ubc7p (Ptak et al., 2001), which in-
teracts with Hrd1p and is the primary UBC required for
Hrd1p-mediated degradation (Bays et al., 2001; Deak
and Wolf, 2001). Given the homology between Hrd1p
and San1p and the involvement of identical and highly
similar UBCs, we speculate that the two PQC degrada-
tion systems may have evolved from a common path-
way, with Hrd1p anchored to the ER and San1p
targeted to the nucleus.
Although we have identified four mutant protein sub-
strates of the SAN1 system, we cannot yet explain what
hallmarks of the mutant proteins are recognized as “ab-
errant” by this system (e.g., exposed hydrophobic
patches, atypical posttranslational modifications, ag-
gregation, etc.). Clearly, whatever is recognized as ab-
errant does not necessarily coincide with complete loss
of protein activity. Otherwise, the sir4-9 and cdc68-1
phenotypes would not have been suppressed by delet-
ing SAN1.
We also do not yet know what properties of San1p
allow it to recognize aberrant proteins. Is aberrant pro-
tein targeting an autonomous feature of San1p, or does
San1p engage ancillary factors, such as protein chap-
erones, to target aberrant proteins for ubiquitination? Italso is not clear if San1p targets aberrant proteins from
all regions of the nucleus or if San1p action is restricted
to aberrant chromatin-associated proteins such as the
ones examined in this study.
SAN1 Reduces Cellular Stress
In support of San1p’s role in nuclear PQC, san1D cells
grown in synthetic media had a transcript-microarray
signature indicative of a cellular stress response. Of the
30 upregulated genes, 29 are induced under cellular
stress conditions, 18 have STRE in their promoters, and
7 are protein chaperones. Of the chaperones, HSP26
and HSP104 are implicated in nuclear protein homeo-
stasis (Parsell et al., 1994; Rossi and Lindquist, 1989);
overexpression of HSP82 or HSC82 partially sup-
presses the temperature sensitivity of the cdc13-1 al-
lele (Grandin and Charbonneau, 2001), which encodes
one of the San1p substrates we identified, and Hsp12p,
Hsp26p, Hsp104p, and Ssa4p are localized to the nu-
cleus (Chughtai et al., 2001; Huh et al., 2003; Kawai et
al., 1999; Rossi and Lindquist, 1989). The increased ex-
pression of these genes in san1 cells is consistent
with the idea that loss of SAN1 results in the accumula-
tion of aberrant proteins in the nucleus, which in turn
triggers a cellular response that attempts to refold or
otherwise sequester the aberrant nuclear proteins. By
extension, we propose that San1p normally rids the nu-
cleus of aberrant proteins, and its presence alleviates
the need for such a response.
The increased expression of protein chaperones may
buffer the cell from dramatic phenotypic effects when
SAN1 is absent. In fact, the low level of chronic stress
that san1 cells are under may precondition them for
additional challenges, similar to what occurs in thermo-
tolerance (Kregel, 2002). This may explain why a signifi-
cant growth difference between san1 and wild-type
cells was not observed under standard lab conditions
or after exposure to physical and chemical challenges.
The use of alternate mechanisms to handle aberrant
proteins when degradation is alleviated appears to be
typical for PQC, as evidenced by what occurs in ER
PQC (Friedlander et al., 2000; Travers et al., 2000).
The induction of the stress response in san1 cells
might also be explained if SAN1 facilitates the rapid
and continuous degradation of a positive regulator of
stress response genes. In the absence of SAN1, the
positive regulator would rise above a critical threshold
required for activation of the stress response. However,
we find this explanation unlikely, since a similar stress
response was not detected when cells were grown in
YEPD media. Instead, the differential response implies
that the metabolism of cells grown in synthetic media
generated more aberrant nuclear proteins than when
cells were grown in rich media.
San1p as a Last Line of Proteolytic Defense
against Aberrant Nuclear Proteins
One implication of our findings is that the SAN1 system
functions downstream of protein production, recogniz-
ing determinants in aberrant proteins that were not de-
tected by earlier cytoplasmic PQC checkpoints, which
in principle should act on aberrant proteins before they
become nuclear localized. If San1p substrates were de-
Cell
812Pstroyed by cytoplasmic PQC, the degradation and,
Sconsequently, the temperature-sensitive phenotypes of
uboth the Sir4-9 and Cdc68-1 proteins would not be
l
suppressed by loss of SAN1 function (Schnell et al.,
1989; Xu et al., 1993). Why are cytoplasmic PQC degra- Y
ydation pathways unable to target the mutant San1p
substrates for destruction? Perhaps there are environ-
mental differences between the cytoplasm and nu- D
cleus, such that the determinants of aberrancy are only P
revealed upon import into the nucleus. Alternatively, s
ssuch determinants may be hidden from cytoplasmic
pPQC by proteins that function as escorts prior to
anuclear import, or the determinants may be uncovered
fduring nuclear import itself. Given the failure of earlier
a
PQC checkpoints to recognize these aberrant proteins, m
it may be that the cell uses San1p as a last line of pro- w
iteolytic defense against accumulation of aberrant pro-
cteins in the nucleus, initiating degradation when other
cPQC pathways upstream in the hierarchy of PQC fail.
fAs noted above, a lack of SAN1-mediated nuclear
2
PQC degradation manifests a stress response in S. cer- E
evisiae. This may be indicative of a cellular pathology m
Pthat can occur in any eukaryotic cell, including those
nassociated with some neurodegenerative diseases in
which there is accumulation and aggregation of mutant
proteins in the nucleus. From our sequence-based U
searches, we have identified homologs of San1p in a G
(number of fungi (data not shown). Using those in sub-
isequent iterative searches, we found proteins with re-
agions of similarity, including the noncanonical RING
idomain, in metazoa and plants, indicating that an anal-
a
ogous pathway may exist in other species. In metazo- m
ans, nuclear PQC may be most critical in cell types that 1
lremain in a nondividing state for long periods of time,
usuch as neural and muscle cells. We speculate that the
2severity in onset of nuclear protein aggregation dis-







Reagents were from New England Biolabs (Beverley, Massachu- (
Usetts), Sigma (St. Louis, Missouri), and Fisher (Pittsburgh, Pennsyl-
vania). Nitrocellulose (Protran, pore size 0.2 M) was from a
mSchleicher and Schuell (Keene, New Hampshire). Mouse anti-Myc,
anti-VSV, and anti-HA antibodies were from Sigma (St. Louis, Mis- F
bsouri) and used at 1:10,000 dilutions. Mouse anti-HSV antibody was
from Novagen (Madison, Wisconsin) and used at a 1:10,000 dilu- S
mtion. Goat anti-Sir2p polyclonal antibodies and donkey anti-goat
HRP-conjugated antisera were from Santa Cruz Biotechnology G
(Santa Cruz, California) and used at a 1:2000 dilutions. Rabbit anti-
Cdc68p antisera was kindly provided by Tim Formosa (University d
eof Utah) and used at a 1:1000 dilution. Affinity-purified rabbit anti-
Sir4p antibodies were kindly provided by Danesh Moazed (Harvard t
mUniversity) and used at a 1:2000 dilution. Rabbit anti-Sir4p antisera
were from Covance (Princeton, New Jersey), after providing them d
wwith GST-Sir4p (C1) purified as previously described (Moazed et
al., 1997), and used at a 1:500 dilution. ECL chemiluminescence f
Preagents, sheep anti-mouse, and donkey anti-rabbit HRP-conju-
gated antisera were from Amersham Biosciences (Piscataway, New i
NJersey) and used at 1:2000 dilutions. FastFlow rProtein G-agarose
was from Repligen (Waltham, Massachusetts). Purified yeast E1 [
1enzyme, human UbcH5a, ubiquitin, Mg-ATP, and MG-132 were from
Boston Biochem (Boston, Massachusetts). GST-Bind resin was i
Sfrom Novagen. Talon resin was from BD Biosciences Clontech (Palo
Alto, California). mlasmids and Yeast Strains
tandard molecular biology techniques were used. All plasmids
sed in this study and brief descriptions of their construction are
isted in Table S1.
Standard yeast methods were used. Recipes for YEPD media and
C media can be found at http://www.fhcrc.org/labs/gottschling. All
east strains used in this study are listed in Table S2.
egradation Assays
rotein degradation was assessed by cycloheximide-chase assays
imilar to previously described (Gardner and Hampton, 1999), with
ome changes. Cells were usually grown in YEPD media to an ap-
roximate cell density of 2 × 107 cells/ml at the permissive temper-
ture of 20°C or 25°C before addition of cycloheximide (50 g/ml
inal concentration), and further incubated at the restrictive temper-
tures of 30°C, 34°C, or 37°C for 0–3 hr after addition of cyclohexi-
ide. In some cases, cells were grown first in YC + 3% raffinose,
ith galactose added to a final concentration of 3% and cultures
ncubated for 4 hr prior to addition of cycloheximide. In other
ases, the proteasome inhibitor MG-132 was added to a final con-
entration of 25 g/ml, and cultures were further incubated at 25°C
or 30 min prior to addition of cycloheximide. Cells were lysed in
00 l SUMEB (8 M urea, 1% SDS, 10 mM MOPS [pH6.8], 10 mM
DTA, 0.01% bromophenol blue) + 10 mM PMSF. Fifteen to thirty
icroliter samples of the cellular lysates were resolved on 8% SDS-
AGE gels, the proteins transferred to nitrocellulose, and immu-
oblotted with the appropriate antibody.
biquitination Assays
ST fusions of San1p were purified per manufacturer’s instructions
Novagen GST-Bind kit) from 100 ml LB + amp cultures, which were
nitially grown at 37°C to an optical density (OD600) of 0.3. IPTG was
dded to a final concentration of 0.8 mM and the cultures were
ncubated for 6 hr at 37°C. Cells were harvested by centrifugation
nd then frozen at −80°C overnight. Frozen cells were lysed in 20
l lysis buffer (20 mM Tris-HCl [pH8.0], 200 mM NaCl, 1 mM EDTA,
mM EGTA) + 10 mM PMSF + 10 mM benzamide + 200 g/ml
ysozyme. Clarified lysates were loaded onto 1.5 ml glutathione col-
mns prewashed with 5 ml lysis buffer. Columns were washed with
0 ml lysis buffer then 20 ml wash buffer (20 mM HEPES-KOH
pH7.6], 350 mM NaCl, 1 mM DTT). Bound proteins were eluted
ith 10 ml wash buffer + 10 mM glutathione. Samples containing
urified GST-San1 protein were combined and concentrated using
Centricon10 (Millipore, Bedford, Massachusetts).
In vitro ubiquitination assays were performed similar to pre-
iously described (Lorick et al., 1999), with some changes. Fifteen
icroliter reactions containing 0.08 g ubiquitin activating enzyme
yeast Uba1p), 0.1 g ubiquitin conjugating enzyme (human
bcH5a), 1.75 g purified GST-San1p (or its mutant variants or GST
lone), 2.5 g ubiquitin, 2 mM Mg-ATP, 50 mM Tris-HCl (pH7.5), 2.5
M MgCl2, and 0.5 mM DTT were incubated at 25°C for 90 min.
ifteen microliters SUMEB was added to each sample and incu-
ated at 65°C for 10 min. The entire reaction was resolved on 8%
DS-PAGE gels, the proteins transferred to nitrocellulose, and im-
unoblotted with anti-ubiquitin monoclonal antibody (Kahana and
ottschling, 1999).
In vivo ubiquitination assays were performed similar to previously
escribed (Gardner and Hampton, 1999), with modifications. Strains
xpressing either 1Myc-Sir4p or 1Myc-Sir4-9p and a triple HA-epi-
ope-tagged ubiquitin expressed from the constitutive TDH3 pro-
oter were grown in 20 ml YC Ura- media to an approximate cell
ensity of 2 × 107 cells/ml. Cultures were divided into 2–5 ml aliquots,
ith one aliquot incubated at 25°C and the other incubated at 34°C
or 20 min. Cellular lysates were prepared in 200 l SUME + 10 mM
MSF + 5 mM N-ethylmaleimide (NEM). 1Myc-Sir4 proteins were
mmunoprecipitated in 1 ml IP buffer (15 mM Na2PO4, 150 mM
aCl, 2% Triton-X100, 0.1% SDS, 0.5% deoxycholate, 10 mM EDTA
pH7.5]) + 10 mM PMSF + 5 mM NEM + 20 l anti-Sir4p antibodies.
00 l FastFlow rProtein G-agarose was used to capture the
mmunocomplexes. Proteins were eluted from beads using 60 l
UMEB + 5% β-mercaptoethanol and incubation at 65°C for 10
in. Ten microliter or forty microliter samples were resolved on 8%
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813SDS-PAGE gels, proteins transferred to nitrocellulose, and immu-
noblotted with either an anti-Myc antibody or an anti-HA antibody.
Transcript DNA Microarrays
Transcript DNA microarrays were performed similar to previously
described (Fazzio et al., 2001). Three independent san1D cultures
and three independent wild-type cultures were grown to midlog
phase at 30°C in 50 ml YEPD or YC media. Dye-reversal experi-
ments were performed to identify sequence-specific dye biases.
Statistical analysis of microarray data was performed as previously
described (Cullen et al., 2004). The entire normalized data set is in
Table S3.
Supplemental Data
Supplemental Data include one figure, three tables, and Supple-
mental Experimental Procedures and can be found with this article
online at http://www.cell.com/cgi/content/full/120/6/803/DC1/.
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